Kate Young
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 10, 2026
Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical Model.Jan Mikelson, Richard Birnie, Grant McCarthy
|Mar 13, 2026
The broad societal value of pembrolizumab for women's cancer in Canada.Elizabeth Brook, Karl Patterson, Nishini Wijenayake
|Sep 17, 2025
Evaluating the broad societal value of pembrolizumab in women's cancer in Brazil.Nishini Wijenayake, Daniel Ladino, Karl Patterson
|Mar 12, 2024
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden.Lewis Ralph, Kate Young, Navneet Upadhyay
|Jan 31, 2024
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.Grant McCarthy, Kate Young, Matthew Madin-Warburton
Pageof 1
Frequent Collaborators
2 joint publications
Grant McCarthy
2 joint publications
Jan Mikelson
2 joint publications
Raquel Aguiar-Ibáñez
2 joint publications
Karl Patterson
2 joint publications
Annabelle Davies
1 joint publications
Vimalanand Shrikant Prabhu
1 joint publications
Christina Ljungcrantz
1 joint publications
Anna Giertz
1 joint publications
Mariana Rosim
1 joint publications
Elizabeth Brook
